A detailed history of Harbour Investments, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Harbour Investments, Inc. holds 1,371 shares of JAZZ stock, worth $163,258. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,371
Previous 1,389 1.3%
Holding current value
$163,258
Previous $148,000 2.7%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$100.57 - $116.37 $1,810 - $2,094
-18 Reduced 1.3%
1,371 $152,000
Q2 2024

Jul 26, 2024

BUY
$103.94 - $118.98 $103 - $118
1 Added 0.07%
1,389 $148,000
Q1 2024

Jul 22, 2024

SELL
$115.19 - $132.77 $230 - $265
-2 Reduced 0.14%
1,388 $167,000
Q4 2023

Feb 16, 2024

BUY
$114.26 - $136.0 $342 - $408
3 Added 0.22%
1,390 $170,000
Q3 2023

Nov 15, 2023

BUY
$122.0 - $145.31 $610 - $726
5 Added 0.36%
1,387 $179,000
Q2 2023

Aug 14, 2023

SELL
$122.5 - $147.16 $857 - $1,030
-7 Reduced 0.5%
1,382 $171,000
Q1 2023

May 15, 2023

SELL
$133.98 - $160.47 $1,339 - $1,604
-10 Reduced 0.71%
1,389 $203,000
Q4 2022

Feb 15, 2023

SELL
$129.72 - $159.85 $1,816 - $2,237
-14 Reduced 0.99%
1,399 $222,000
Q2 2022

Aug 15, 2022

SELL
$141.59 - $168.66 $2,407 - $2,867
-17 Reduced 1.19%
1,413 $220,000
Q4 2021

Feb 16, 2022

SELL
$119.87 - $145.67 $20,018 - $24,326
-167 Reduced 10.46%
1,430 $182,000
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $2,958 - $4,250
-23 Reduced 1.42%
1,597 $208,000
Q2 2021

Aug 16, 2021

BUY
$160.2 - $186.42 $160 - $186
1 Added 0.06%
1,620 $288,000
Q1 2021

Aug 17, 2021

BUY
$150.19 - $173.5 $242,707 - $280,376
1,616 Added 53866.67%
1,619 $266,000
Q1 2021

May 12, 2021

BUY
$150.19 - $173.5 $450 - $520
3 New
3 $1,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.46B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.